Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

19 Aug 2010 17:38

RNS Number : 3696R
Oryx International Growth Fund Ld
19 August 2010
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

 

INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2010

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 April 2010 to 30 June 2010, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

 

Manager's Review

The FTSE All - Share TR Index (£) returned -11.80% in the three months ended 30 June 2010 as risk aversion continued among investors worried about a series of macro economic concerns, including poor US economic data, a slowdown in China and fears of a double-dip recession in the UK. UK small-cap stocks out performed the broad index, with the FTSE Small Cap TR (£) Index returning -6.07%. Against this backdrop, the Fund's NAV rose by 3.13%, whilst its share price increased by 5.39% to £1.76.

 

 

Material Transactions

Since 1 April 2010 the Company purchased for cancellation a total of 1,482,971 ordinary shares at a gross price of £1.72 per share.

 

Material Events

There were no material events during the quarter ended 30 June 2010.

 

Report and Accounts

On 23 June 2010, the Company posted its Annual Report and Accounts for the year ended 31 March 2010, to Shareholders. On 5 July 2010, the Company published a circular containing notice of the Company's Annual General Meeting and details in relation to the proposed Rule 9 waiver.

 

Financial Highlights

 

 

30 June 2010

31 March 2010

31 December 2009

30 September 2009

 

 

 

 

 

NAV

£2.35

£2.28

£2.26

£2.21

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.4961

 

1.5169

 

1.4378

 

1.5994

 

 

 

 

 

** Sterling adjusted

 

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2010

 

%

RPC Group Plc

7.26%

Chrysalis Holdco

7.03%

Avanti Communications Group Plc

6.21%

Inspired Gaming Group Plc

6.13%

Catalyst Media Group Plc

5.55%

Tenon Group Plc

5.21%

Orthoproducts Limited

5.15%

Gleeson (M J) Group Plc

4.80%

BBA Aviation Plc

4.63%

Bionostics Holdings Limited Pref Shs

4.34%

Bavaria Industriekapital AG

4.19%

Quarto Group Plc

3.93%

Augean Plc

3.32%

Nastor Investement Limited

3.09%

Journey Group Plc

3.04%

Vislink Plc

2.76%

AssetCo Plc

2.61%

AC Management Services Limited

2.18%

Green CO2 Plc

2.09%

Asset Co (Abu Dhabi) Plc

2.02%

% of total portfolio

85.54

 

The financial information for the quarter ended 30 June 2010 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUQWRUPUGQB
Date   Source Headline
10th Aug 202310:44 amRNSNet Asset Value(s)
2nd Aug 20237:00 amRNSHolding(s) in Company
26th Jul 20234:00 pmRNSNotice of AGM
11th Jul 202311:23 amRNSNet Asset Value(s)
6th Jul 20237:00 amRNSAnnual Financial Report
14th Jun 20239:25 amRNSDirector Declaration
8th Jun 20234:11 pmRNSNet Asset Value(s)
8th Jun 20238:59 amRNSDirector Declaration
11th May 20234:46 pmRNSNet Asset Value(s)
14th Apr 20239:08 amRNSNet Asset Value(s)
9th Mar 202310:30 amRNSPrevious Shareholding in WANdisco plc
7th Mar 20235:24 pmRNSNet Asset Value(s)
9th Feb 20239:49 amRNSNet Asset Value(s)
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
19th Jan 202310:04 amRNSDirector/PDMR Shareholding
13th Jan 20234:02 pmRNSDirector/PDMR Shareholding
11th Jan 202312:11 pmRNSNet Asset Value(s)
13th Dec 202211:36 amRNSNet Asset Value(s)
9th Dec 20227:00 amRNSHalf-year Report
10th Nov 202210:01 amRNSNet Asset Value(s)
24th Oct 20225:26 pmRNSTR1: Notification of major holdings
12th Oct 20229:30 amRNSNet Asset Value(s)
3rd Oct 20227:00 amRNSTotal Voting Rights
16th Sep 20227:00 amRNSDirectorate Change
12th Sep 20224:40 pmRNSSecond Price Monitoring Extn
12th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 202212:49 pmRNSNet Asset Value(s)
18th Aug 202210:31 amRNSResult of Annual General Meeting
9th Aug 202212:56 pmRNSNet Asset Value(s)
15th Jul 20224:45 pmRNSNotice of AGM
12th Jul 202212:27 pmRNSNet Asset Value(s)
8th Jul 20227:00 amRNSAnnual Financial Report
6th Jul 20225:07 pmRNSHolding(s) in Company
23rd Jun 20222:30 pmRNSHolding(s) in Company
22nd Jun 20225:04 pmRNSHolding(s) in Company
15th Jun 202212:21 pmRNSNet Asset Value(s)
12th May 202212:51 pmRNSNet Asset Value(s)
28th Apr 20225:39 pmRNSHolding(s) in Company
11th Apr 20222:13 pmRNSNet Asset Value(s)
10th Mar 202210:00 amRNSNet Asset Value(s)
9th Feb 20221:10 pmRNSNet Asset Value(s)
13th Jan 20221:16 pmRNSNet Asset Value(s)
17th Dec 20217:00 amRNSHalf-Yearly Results
10th Dec 202112:50 pmRNSNet Asset Value(s)
17th Nov 20217:00 amRNSHolding(s) in Company
11th Nov 202112:32 pmRNSNet Asset Value(s)
26th Oct 202111:24 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.